news
Oestrogen levels do not rise for transgender men treated with testosterone therapy
Testosterone therapy is not associated with a rise in oestrogen levels among transgender men, according to a new study led by Boston Medical Center...
List view / Grid view
Drug delivery
news
Treating menopause symptoms reduces abdominal fat tissue
Women who undergo hormone therapy to relieve menopausal symptoms tend to have less fat tissue, particularly in the abdomen, than other menopausal women...
news
Antibiotic use increases risk of severe viral disease in mice
Killing gut bacteria with drugs weakens immune response...
news
Kineret reduces inflammation in stroke patients
An anti-inflammatory drug given to patients in the early stages of a stroke has been shown to reduce harmful inflammation...
news
NIH scientists say advanced vaccines could limit future outbreaks
Novel vaccine technologies are critical to improving the public health response to infectious disease threats that continually emerge and re-emerge, according to scientists at the NIAID...
news
A pioneering conference will address the threat of poor quality medicines on a global scale
A pioneering academic conference will bring together, for the first time, people from all over the world dealing with the problem of poor quality medicines and their impact on public health...
news
Injectable MDP-hydrogel may help heal diabetic ulcers
Researchers have created a hydrogel that is capable of helping the body heal and that may also be particularly good at treating wounds related to diabetes...
news
T-VEC treatment shows promise for treating advanced stage liver tumours
Phase 1 data supports the use of image-guided therapy for difficult to treat cancer...
news
ACG GROUP: ‘World’s only market-ready track & TR solutions provider’ for EUFMD – Inspections business launches groundbreaking Track & Trace capabilities.
ACG is the ‘world’s only market ready Track & Trace solutions provider', in accordance with the EU Falsified Medicines Directive (EUFMD) - which comes into effect in February 2019...
news
DPP-4 inhibitors may be linked to inflammatory bowel disease
The use of certain diabetes drugs, known as dipeptidyl peptidase-4 inhibitors, are associated with an increased risk of inflammatory bowel disease...
news
Programming DNA to deliver cancer drugs
New technology could lead to the development of new cancer therapies...
news
Tamoxifen and raloxifene slow down the progression of muscular dystrophy
Long-term treatment with selective estrogen receptor modulators improves muscle, respiratory, and skeletal function without weakening bone in new mouse studies...
news
Wickham Laboratories to exhibit at Making Pharmaceuticals UK 2018
Wickham Laboratories Ltd will exhibit on Stand 309 at the Making Pharmaceuticals Conference on 24 – 25 April 2018 at Ricoh Arena, Coventry...
news
Dimethandrolone undecanoate shows promise as a male birth control pill
A new birth control pill for men appears to be safe when used daily for a month, with hormone responses consistent with effective contraception...
news
H7N9 influenza vaccine clinical trials begin
Two new clinical trials testing an experimental vaccine to prevent influenza caused by an H7N9 influenza virus are now enrolling volunteers at sites across the United States...
